A machine learning analysis to evaluate the outcome measures in inflammatory myopathies

Maria Giovanna Danieli1, Alberto Paladini2, Eleonora Longhi3

  • 1SOS Immunologia delle Malattie Rare e dei Trapianti, AOU delle Marche & Dipartimento di Scienze Cliniche e Molecolari, Università Politecnica delle Marche, via Tronto 10/A, 60126 Torrette di Ancona, Italy; Postgraduate School of Allergy and Clinical Immunology, Università Politecnica delle Marche, via Tronto 10/A, 60126 Ancona, Italy.

Summary

Artificial intelligence (AI) identified key predictors of long-term outcomes in Idiopathic Inflammatory Myopathies (IIM). Machine learning models accurately forecast muscle strength and disease activity, aiding future treatment strategies for IIM patients.